方达控股(1521.HK)完成对观合医药收购,进一步强化全球中心实验室能力布局

全景网
Mar 06

2026年3月3日,泰格医药集团旗下方达控股宣布已正式完成对观合医药的收购。此次收购将进一步完善方达在全球中心实验室领域的布局,强化其在中国及亚太地区的综合服务能力。观合医药是中国领先的临床研究实验室服务提供商,累计支持超过1,500项临床试验,覆盖多个治疗领域。公司长期按照GCP规范开展运营,实验室通过CAP认证,同时获得NGSP Level 1实验室资质,并具备放射性乙类工作场所资质。凭借成熟...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10